Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    nichd Primary Immunodeficiency (PI)
Show Display Options
RSS Create an RSS feed from your search for:
nichd Primary Immunodeficiency (PI)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Conditions: HIV Infections;   Hyperlipidemia
Intervention: Drug: Atorvastatin
2 Completed Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART
Conditions: HIV Infections;   Malaria
Interventions: Drug: Lamivudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
3 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
4 Completed
Has Results
Treatment Options for Protease Inhibitor-exposed Children
Conditions: HIV/AIDS;   HIV Infections
Interventions: Drug: Efavirenz (EFV);   Drug: Lopinavir/ritonavir (LPV/r);   Drug: Stavudine (D4T);   Drug: Abacavir (ABC)
5 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
6 Unknown  Pediatric Nevirapine Resistance Study
Conditions: AIDS;   HIV Infections
Intervention: Drug: nevirapine
7 Terminated Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)

Indicates status has not been verified in more than two years